BOLT Stock Analysis: Buy, Sell, or Hold?
BOLT - Bolt Biotherapeutics, Inc. Common Stock
$3.21
-0.24 (-6.96%)
▼
5d:
-17.05%
30d:
-23.75%
90d:
-33.54%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When BOLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BOLT is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BOLT is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BOLT is currently trading at $3.21, which is considered oversold relative to its 30-day fair value range of $3.73 to $4.20.
Technical Outlook: Technically, BOLT is in a downtrend. The price is currently testing key support at $3.13. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: BOLT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $41.00 (+1177.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BOLT is in a downtrend. The price is currently testing key support at $3.13. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: BOLT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $41.00 (+1177.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.73 -
$4.20
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 1177.3% below Wall St target ($41.00)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.73 -
$4.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.13
Resistance Level
$4.15
Current Trend
Downtrend
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.01
Wall Street Target
$41.00
(+1177.3%)
Revenue Growth (YoY)
-97.9%
Share & Embed Analysis
Last updated: August 13, 2026 10:11 PM ET
Data refreshes hourly during market hours. Next update: 11:11 PM
Data refreshes hourly during market hours. Next update: 11:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 41 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 53 HOLD |
|
TNYA
Tenaya Therapeutics Inc |
STRONG BUY
9 analysts |
$3 | 69 BUY |
